Hypofractionated Radiation Therapy for Prostate Cancer

 

As the COVID-19 pandemic continues, many cancer patients are having to make the difficult decision to continue with their current cancer regimen or delay treatments.  Cancer patients and physicians must carefully weigh the potential benefit of routine cancer care versus the risk of COVID-19. To help ease these decisions, several peer-reviewed, non-profit cancer care organizations […]

 

Learn More

 

 

Prostate Cancer Treatment and Sexual Function

 

When deciding which treatment option is best for their prostate cancer, men take numerous factors into consideration.  While their physician’s recommendation does play an important role in the treatment decision, in the end, most men make the choice that is best for them.  That choice is often based on treatment outcomes and side effects, and […]

 

Learn More

 

 

Prostate Cancer: Know Your Options

 

Thanks to advancements in research and treatment methods, men diagnosed with prostate cancer have more options and resources available to them than ever before. Whether you or a loved one has been newly diagnosed with prostate cancer, talking to your doctor to learn more about the disease and treatments that are right for you is […]

 

Learn More

 

 

Dr. Hirsch Talks with WGN About Beating Prostate Cancer

 

One man shares how he was able to successfully get through prostate cancer treatment and get back to enjoying time with his wife. We also learn why it’s important to ask your doctor about treatment options if you’re diagnosed, and how prostate cancer is often detected.

 

Learn More

 

 

Dr. Heuser’s CyberKnife Story

 

Watch general surgeon, Dr. Louis Heuser, talk about why he chose CyberKnife for the treatment of his prostate cancer. Dr. Heuser was very happy with the quick treatments and the fact that he was able to stay close to home and continue to work and see his patients. It’s Your Prostate, Your Cancer, Your Choice.

 

Learn More

 

 

10-year Data Shows CyberKnife Provides Excellent Long-term Control of Low-Risk Prostate Cancer

 

Accuray, the company that develops and manufactures the CyberKnife® Robotic Radiosurgery System, the system that Illinois CyberKnife uses to treat cancer, recently announced the results of the first study that evaluated the use of stereotactic body radiation therapy (SBRT) in low-risk prostate cancer 10 years post treatment. The study titled, “Stereotactic Body Radiotherapy for Low-Risk […]

 

Learn More

 

 

American Urological Association, American Society for Radiation Oncology, and the Society of Urologic Oncology Release Joint Prostate Cancer Guidelines

 

Last week, the American Urological Association (AUA), the American Society for Radiation Oncology (ASTRO), and the Society of Urologic Oncology (SUO) released collaborative clinical guidelines for managing localized prostate cancer which offers a framework for shared decision-making between physicians and patients.  Through this collaboration, the committee provided guidance on active surveillance and on which treatments […]

 

Learn More

 

 

The U.S. Preventive Services Task Force Updates Screening Guidelines for Prostate Cancer

 

The U.S. Preventive Services Task Force (USPSTF) recently updated their prostate screening recommendations. On April 11, 2017, the USPSTF issued an updated draft recommendation on screening for prostate cancer.  The updated recommendation changes the grade for PSA-based screening from “D” to “C” for men 55 – 69 years of age.  As a result, the USPSTF […]

 

Learn More

 

 

Scientists Find New Gene Tool for Predicting Course of Prostate Cancer

 

A recent research paper in Oncotarget, a weekly peer-reviewed open access medical journal covering research on all aspects of oncology, reported that researchers from UR Medicine’s Wilmot Cancer Institute and Roswell Park Cancer Institute have discovered a possible new tool for predicting whether prostate cancer will reoccur following surgery based on the expression patterns of […]

 

Learn More

 

 

Prostate Cancer: Take Time to Decide infographic

 

 

Learn More